Related Experiment Videos

[Slow onset septic arthritis by Scedosporium apiospermum after periarticular infiltration]

Antonio Ramos Martínez1, Beatriz Orden Martínez, Jessica Polo Laborda

  • 1Unidad de Enfermedades Infecciosas, Servicio de Medicina Interna, Hospital Universitario Puerta de Hierro, Universidad Autónoma de Madrid, Majadahonda, Madrid, España. aramos220@gmail.com

Abstract

Insights

Fungal arthritis caused by Scedosporium apiospermum can be challenging to treat. Voriconazole combined with surgical debridement offers an effective solution for this rare infection.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Rheumatology

Background:

  • Fungal arthritis typically arises from bloodstream infections, predominantly affecting immunocompromised individuals or intravenous drug users.
  • In immunocompetent hosts, direct inoculation via invasive devices is the common route for fungal joint infections.
  • Limited data exists on azole antifungal efficacy for fungal arthritis in immunocompetent patients.

Observation:

  • A case of Scedosporium apiospermum-induced arthritis presented with insidious onset.
  • The patient's condition did not improve with posaconazole and caspofungin.
  • Successful treatment was achieved through surgical intervention and voriconazole therapy.

Findings:

  • Scedosporium apiospermum can cause a slowly progressing arthritis.
  • Posaconazole and caspofungin demonstrated limited efficacy against this fungal arthritis.
  • Voriconazole, in conjunction with surgical debridement, led to complete resolution of the infection.

Implications:

  • Surgical debridement is a critical component in managing Scedosporium apiospermum arthritis.
  • Voriconazole represents a viable and effective therapeutic option for this specific fungal joint infection.
  • This case highlights the importance of considering fungal etiologies in refractory arthritis, even in immunocompetent individuals.